NA
Nirmal Atmaram Bhatia
About Nirmal Atmaram Bhatia
Data last updated:
Nirmal Atmaram Bhatia is a Cfo at Veeda Clinical Research Limited (since 2021), Director at Bioneeds India Private Limited (since 2021) and Director at Ingenuity Biosciences Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma, Travel and Hospitality and Life Sciences. The 4 current companies with reported revenue have a combined latest revenue of ₹738 Cr; the largest is Veeda Clinical Research Limited at ₹621 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Veeda Clinical Research Limited U73100GJ2004PLC044023 | Cfo | 22 Jun 2021 | 2004 | ₹621 Cr (FY 2025) | Active |
 Bioneeds India Private Limited U01409KA2007PTC042282 | Director | 22 Mar 2021 | 2007 | ₹116 Cr (FY 2024) | Active |
 Ingenuity Biosciences Private Limited U74999GJ2021PTC120292 | Director | 16 Feb 2021 | 2021 | ₹30,000 (FY 2025) | Active |
| Amthera Life Sciences Private Limited U74999KA2017PTC104317 | Director | 02 Dec 2024 | 2017 | ₹18,360 (FY 2025) | Active |
Board colleagues of Nirmal Atmaram Bhatia
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmal Atmaram Bhatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmal Atmaram Bhatia
Nirmal Atmaram Bhatia currently holds 4 directorships: Veeda Clinical Research Limited (Cfo, since 22 Jun 2021, revenue ₹621 Cr (FY 2025)); Bioneeds India Private Limited (Director, since 22 Mar 2021, revenue ₹116 Cr (FY 2024)); Ingenuity Biosciences Private Limited (Director, since 16 Feb 2021, revenue ₹30,000 (FY 2025)); Amthera Life Sciences Private Limited (Director, since 02 Dec 2024, revenue ₹18,360 (FY 2025)).
Nirmal Atmaram Bhatia was first appointed on 16 Feb 2021 as Director at Ingenuity Biosciences Private Limited. The most recent appointment on record is 02 Dec 2024 at Amthera Life Sciences Private Limited.
The 4 current companies of Nirmal Atmaram Bhatia that report revenue have a combined latest revenue of ₹738 Cr: Veeda Clinical Research Limited ₹621 Cr (FY 2025); Bioneeds India Private Limited ₹116 Cr (FY 2024); Ingenuity Biosciences Private Limited ₹30,000 (FY 2025); Amthera Life Sciences Private Limited ₹18,360 (FY 2025).
The current boards of Nirmal Atmaram Bhatia's companies include Apurva Bhupendra Shah (Veeda Clinical Research Limited), Binoy Hasmukh Gardi (Veeda Clinical Research Limited), Binoy Hasmukh Gardi (Veeda Clinical Research Limited), David Paul Kenny (Veeda Clinical Research Limited), Georgios Kouvatseas (Veeda Clinical Research Limited), Ioannis Orfanidis (Veeda Clinical Research Limited), among others.